Esperion Therapeutics, Inc. (ESPR)
3.13
0.00 (0.00%)
USD |
NASDAQ |
May 29, 16:00
3.13
0.00 (0.00%)
After-Hours: 20:00
Esperion Therapeutics EPS Diluted (Quarterly) : -0.1002 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Merck & Co., Inc. | -1.715 |
| Nektar Therapeutics | -1.815 |
| ANI Pharmaceuticals, Inc. | 1.276 |
| Corcept Therapeutics, Inc. | -0.2988 |
| Eli Lilly & Co. | 8.255 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -25.20M |
| Revenue (Quarterly) | 80.10M |
| Total Expenses (Quarterly) | 105.30M |
| Enterprise Value | 1.193B |
| Gross Profit Margin (Quarterly) | 56.84% |
| Profit Margin (Quarterly) | -31.45% |
| Earnings Yield | -3.30% |
| Operating Earnings Yield | 10.37% |
| Normalized Earnings Yield | -3.307 |